An exploratory study to assess the effectiveness of Virtual Reality assisted Guided Imagery on quality of life of cancer patients undergoing Chemo-radiation treatment.

Phase 2

Not yet recruiting

• Conditions: Neoplasms,

• Registration Number: CTRI/2025/05/087252
• Lead Sponsor: SMRATA Trust

Brief Summary

Cancer significantly impacts patients’ mental and physical well-being, with 25% to 60% reporting clinical distress. Chemoradiation, a common treatment, often leads to debilitating side effects. Guided imagery, especially when delivered through virtual reality (VR), has emerged as a promising non-invasive intervention to alleviate distress, reduce pain and anxiety, and improve mood and overall well-being. This study aims to assess the effectiveness of VR-assisted guided imagery in reducing distress among patients undergoing chemoradiation. The hypothesis posits that patients receiving this intervention will show higher quality-of-life scores (FACT-G) compared to those receiving standard care. A quasi-experimental, non-randomized design will be used.

Detailed Description

Not available

Study Timeline

• Last Update Posted: 2025-05-20
• Study Start: 2025-08-06

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 160

Inclusion Criteria

1. New patients aged 18 years to 70 years with a confirmed cancer diagnosis and enrolled in chemo-radiation 2) Able to provide informed consent 3) Eastern Cooperative Oncology Group (ECOG) performance status of 0–2 in order to prevent biasness among the patients and to check the patient’s performance status 4) Able to understand and complete the study questionnaires.

Exclusion Criteria

1. Severe cognitive impairment or active psychiatric illness 2) Visual or auditory impairments that would prevent use of the VR device 3) Concurrent participation in other psychosocial interventions 4) History of seizures or motion sickness (contraindicated for VR use).

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Quality of Life using the FACT G	Weekly

Secondary Outcome Measures

Name	Time	Method
Distress reduction using the Distress Thermometer Scale	Weekly

Trial Locations

Locations (1)

DAE-Civil Hospital Cancer Wing; 🇮🇳 Hills, MEGHALAYA, India

DAE-Civil Hospital Cancer Wing

🇮🇳Hills, MEGHALAYA, India

Dr Anisha Mawlong

Principal investigator

9436924322

anishamawlong@gmail.com